To Find the best Antigens for Cancer, or COVID, Gritstone bio has the EDGE™

From a famous pub in Oxford to a lab on California’s coast, Gritstone founder, and CEO Dr. Andrew Allen tells the story of how his dream, inspired by a legend in cancer immunotherapy, became the reality that is Gritstone bio, a company developing both off-the-shelf and personalized vaccines for cancer – and now COVID – with antigens discovered by their proprietary, machine learning platform, EDGE™.